SCOLR Pharma, Inc. - Investor Relations

Investors

Overview
Annual Reports
Current SEC Filings
    2007 SEC Filings
    2006 SEC Filings
    2005 SEC Filings
    2004 SEC Filings
    2003 SEC Filings
Corporate Governance
Investor FAQ

2005 SEC Filings

12/22/2005 -

Form 8K

Exhibit 99.1, Press Release

12/20/2005 -

Form 8K

Exhibit 99.1, Employment Agreement

12/16/2005 -

Form 8K

11/14/2005 -

Form 10Q, For the Quarterly period ended September 30, 2005

Exhibit 31.1, Certification of CEO

Exhibit 31.2, Certification of PFO

Exhibit 32.1, Certification of CEO

Exhibit 32.2, Certification of PFO

Exhibit 99.1, Press Release

11/09/2005 -

Form 8K

Exhibit 99.1, Advisory Services Agreement

Exhibit 99.2, Summary of SCOLR Pharma, Inc. Non-Employee Director Compensation

10/27/2005 -

Form S-3

Exhibit 5.1, Opinion of DLA Piper Rudnick Cary US LLP

Exhibit 23.1, Consent of Grant Thornton LLP

10/21/2005 -

Form 8K

Exhibit 99.1, Press Release

10/14/2005 -

Form 8K

8/15/2005 -

Form 8K

Exhibit 99.1, Press Release

8/12/2005 -

Form 10Q, For the Quarterly period ended June 30, 2005

Exhibit 31.1, Certification of CEO

Exhibit 31.2, Certification of PFO

Exhibit 32.1, Certification of CEO

Exhibit 32.2, Certification of PFO

8/05/2005 -

Form 8K

Exhibit 10.1, Settlement Agreement and First Amendment

7/13/2005 -

Form 8K

Exhibit 99.1, Press Release

6/16/2005 -

Form 8K

Exhibit 99.1, Amended and Restated Bylaws of SCOLR Pharma, Inc.

Exhibit 99.2, Press Release

5/13/2005 -

Form 10Q, For the Quarterly period ended March 31, 2005

Exhibit 10.2, Summary of Non-Employee Director Compensation

Exhibit 31.1, Certification of CEO

Exhibit 31.2, Certification of PFO

Exhibit 32.1, Certification of CEO

Exhibit 32.2, Certification of PFO

5/12/2005 -

Form 8K

Exhibit 99.1, Press Release

5/02/2005 -

Schedule 14A

4/18/2005 -

Prospectus

4/08/2005 -

Form S-3

Exhibit 5.1, Opinion of DLA Piper Rudnick Gray Cary LLP

Exhibit 23.1, Consent of Grant Thornton LLP, Independent Auditors

3/31/2005 -

Form 10KSB, For the fiscal year ended December 31, 2004

Exhibit 23.1, Consent of Grant Thornton LLP

Exhibit 31.1, Certification of Daniel O. Wilds

Exhibit 31.2, Certification of Gail T. Vitulli

Exhibit 32.1, Certification of Daniel O. Wilds

Exhibit 32.2, Certification of Gail T. Vitulli

3/22/2005 -

Form 8K

Exhibit 99.1, Press Release

3/15/2005 -

Form S-3

Exhibit 5.1, Opinion of DLA Piper Rudnick Gray Cary LLP

Exhibit 23.1, Consent of Grant Thornton LLP, Independent Auditors

2/11/2005 -

Form 8K

Exhibit 4.1, Common Stock Purchase Warrant

Exhibit 10.1, Common Stock Purchase Agreement

Exhibit 10.2, Registration Rights Agreement

Exhibit 10.3, Taglich Brothers, Inc. Letter Agreement

Exhibit 99.1, Press Release

1/25/2005 -

Form 8-K

1/11/2005 -

Form 8-K